Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Quintiles passes data management milestone with 300 EDC trials

Quintiles Transnational : 06 March, 2008  (New Product)
Quintiles Transnational has achieved another major milestone in the management of clinical trial data - 300 clinical trials using Electronic Data Capture (EDC).
The milestone EDC trial is a Phase II study being conducted for Pacgen Biopharmaceuticals of Vancouver, British Columbia, Canada. Pacgen is studying an anti-infective drug for the treatment of oral candidiasis. Quintiles began using EDC in 1999 and has seen acceptance of the technology accelerate since then, with more than 94 EDC trials put into production in 2007.

'At Quintiles, EDC is quickly surpassing paper in the collection of clinical trial data as customers are placing increased value on our ability to give them expert guidance in the appropriate use of this technology, as well as the potential for savings in time and cost,' said Paula Brown Stafford, executive vice president, Global Data Management and Biostatistics, and a member of the CDISC Board of Directors. 'We have been able to demonstrate for the pharmaceutical and biotech industries that EDC, when used properly, can make much better use of available resources.

'With Pacgen, we're working with an emerging biopharmaceutical company that is conducting important research in infectious diseases,' she added. 'Quintiles looks forward to continuing to help Pacgen further develop its pipeline.'
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo